C. Eduardo Corrales, MD, Ryan A. Bartholomew, MD, and colleagues detected a 21% prevalence of radiologic cranial nerves abnormalities in patients with hereditary neuropathies who underwent MRI. They caution physicians not to assume these findings represent pathologies requiring intervention by an otolaryngologist.
Using prospectively collected registry data, researchers at Brigham and Women’s Hospital linked increased severity of sinonasal symptoms in patients with aspirin-exacerbated respiratory disease to both worse patient-reported asthma control and worse objectively measured lung function.
The COVID-19 pandemic has dealt a blow to faculty membership and sponsorship programs at many healthcare institutions. In response, the Brigham is piloting a new Faculty Mentorship and Sponsorship Network Program. Laryngologist and associate surgeon Anju K. Patel, MD, who spearheads the program, discusses its impact.
A 77-year-old woman, whose past medical history included type 2 diabetes, end-stage renal disease and hypertension, presented to the emergency department with a two-month history of severe left ear and facial pain. Imaging demonstrated changes in soft tissue and bone that were concerning for skull base osteomyelitis.
Researchers at Brigham and Women’s Hospital sought to answer whether the association between SNOT-22 and CT results could be improved by rating partial opacification more precisely. Instead, they found the relationship between the two assessment methods is affected by incidental causes of opacification.
Emily Moldoff, NP, Carleton Eduardo Corrales, MD, and Jennifer J. Shin, MD, and colleagues have documented that the noise generated by powered air-purifying respirators creates a substantial barrier to communication during clinical interactions.
Laryngopharyngeal reflux disease (LPR), an inflammatory condition related to the direct and indirect effects of gastroduodenal content reflux, affects up to 30 percent of otolaryngology patients worldwide. The condition leads to symptoms including chronic throat clearing and cough, excess throat mucus, postnasal drip and vocal changes, which can significantly impact the patient’s quality of life.
Researchers at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) are advancing innovative approaches to decrease tumor recurrence rates in patients with HPV-negative squamous cell carcinoma of the head and neck (SCCHN).
A Phase 2 trial run by the Adult Head and Neck Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) is seeking to reduce the side effects of postoperative therapy for certain head and neck cancer patients, helping them have a better quality of life while maintaining cancer cure rates.